Can tighter blood pressure control in pregnancy prevent serious complications?
NCT ID NCT07746271
First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time
Summary
This trial tests whether treating high blood pressure in pregnancy to a stricter target (below 140/90) is better than the usual approach (below 160/110) for women with gestational hypertension or preeclampsia without severe features. About 4,120 pregnant women will be randomly assigned to one of the two blood pressure goals. The study tracks whether the stricter goal reduces a combined set of serious outcomes, including organ damage, early delivery, fetal or infant death, and placental abruption.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Antihypertensive medication (labetalol or nifedipine ER) titrated to a blood pressure goal of <140/90 mmHg
- What this could lead to
- If tighter blood pressure control works, it could reduce serious pregnancy complications like preterm birth and organ damage in women with gestational hypertension or preeclampsia.
- What could go wrong
- The trial is large but open-label, and the tighter goal may increase side effects from medication without improving outcomes. Results are not yet available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION IN PREGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Brown Univeristy
Providence, Rhode Island, 02905, United States
-
Case Western Reserve University
Cleveland, Ohio, 44109, United States
-
Columbia University
New York, New York, 10032, United States
-
Duke University
Durham, North Carolina, 27710, United States
-
Magee Women's Hospital
Pittsburgh, Pennsylvania, 15213, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Ohio State University
Columbus, Ohio, 43210, United States
-
Regents of the University of California San Francisco
San Francisco, California, 94143, United States
-
University of Alabama - Birmingham
Birmingham, Alabama, 35233, United States
-
University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, 27599, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
University of Texas - Houston
Houston, Texas, 77030, United States
-
University of Utah
Salt Lake City, Utah, 84132, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Home visits may boost heart health for pregnant women in nigeria
- Simple alerts may keep At-Risk moms healthy after birth
- Massive trial tests cheap drug to stop Post-C-Section hemorrhage
- New app aims to keep moms-to-be with high blood pressure safer at home
- Phone apps may cut heart risk after pregnancy blood pressure problems
- New blood pressure cuff could save moms from unnecessary C-Sections